| RS34119065 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS34120190 |
MBL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mannose-binding lectin deficiency, Mannose-binding lectin deficiency |
| RS34120922 |
NBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Aplastic anemia, Microcephaly |
| RS34122078 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset ascending hereditary spastic paralysis, Amyotrophic lateral sclerosis type 2 |
| RS34124242 |
ATR
|
Health Risk |
Conflicting classifications of pathogenicity |
Seckel syndrome 1, ATR-related disorder |
| RS34124941 |
NPHS1
|
Health Risk |
Likely pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS34126013 |
MUTYH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS34126315 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34129005 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34130975 |
LEPR
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity due to leptin receptor gene deficiency, Obesity due to leptin receptor gene deficiency |
| RS34133563 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Pyropoikilocytosis |
| RS34134064 |
RECQL4
|
Health Risk |
Pathogenic/Likely pathogenic |
Baller-Gerold syndrome, Rothmund-Thomson syndrome type 2 |
| RS34134328 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, GALC-related disorder |
| RS34135787 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34135972 |
BLNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Agammaglobulinemia 4, autosomal recessive |
| RS34139950 |
C1QA
|
Health Risk |
Pathogenic |
C1Q deficiency, C1Q deficiency |
| RS34141362 |
KIDINS220
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, intellectual disability |
| RS34141917 |
ZNF407
|
Health Risk |
Conflicting classifications of pathogenicity |
ZNF407-related disorder, ZNF407-related disorder |
| RS34146052 |
CC2D1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS34150443 |
TMPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 2, TMPO-related disorder |
| RS34151474 |
MYO3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS34157149 |
MCM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency, MCM4-related disorder |
| RS34159654 |
GNPTAB
|
Health Risk |
Pathogenic |
Pseudo-Hurler polydystrophy, Mucopolysaccharidosis |
| RS34160180 |
HBB
|
Health Risk |
Pathogenic |
Hemoglobinopathy, Hemoglobinopathy |
| RS34161232 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS34161326 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Joubert syndrome 17 |
| RS34165323 |
HBB
|
Health Risk |
Pathogenic |
Hemoglobinopathy, 8 conditions |
| RS34165480 |
MYH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1 |
| RS34169786 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome |
| RS34170727 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS34171453 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34174718 |
TUBB3
|
Health Risk |
Conflicting classifications of pathogenicity |
TUBB3-related disorder, TUBB3-related disorder |
| RS34177347 |
CLIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sarcoma, Sarcoma |
| RS34181110 |
MTHFD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spina bifida, folate-sensitive |
| RS34181302 |
TRAPPC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS34189316 |
VDR
|
Health Risk |
Conflicting classifications of pathogenicity |
Vitamin D-dependent rickets type II with alopecia, Vitamin D-dependent rickets type II with alopecia |
| RS34190279 |
C1QTNF5;MFRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 5, Late-onset retinal degeneration |
| RS34191306 |
BBS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS34193178 |
G6PD
|
Health Risk |
Conflicting classifications of pathogenicity |
G6PD deficiency, Anemia |
| RS34194489 |
PEX26
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 7A (Zellweger), Peroxisome biogenesis disorder 7B |
| RS34196559 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
beta Thalassemia, beta Thalassemia |
| RS34200464 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34206069 |
MCM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency, Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency |
| RS34207306 |
MASP1
|
Health Risk |
Conflicting classifications of pathogenicity |
3MC syndrome 1, 3MC syndrome 1 |
| RS34208370 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, PINK1-related disorder |
| RS34211240 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS34213726 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS34214309 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS34216426 |
SLC12A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypokalemia-hypomagnesemia, SLC12A3-related disorder |
| RS34218908 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
beta Thalassemia, beta Thalassemia |
| RS34220980 |
HBA1
|
Health Risk |
Pathogenic |
Erythrocytosis, familial |
| RS34224064 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 1 |
| RS34224604 |
HBD
|
Health Risk |
Pathogenic |
Delta-0-thalassemia, Delta-0-thalassemia |
| RS34224785 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Posterior polymorphous corneal dystrophy 1, Corneal dystrophy |
| RS34226296 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS34227547 |
TRPV4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2C, Charcot-Marie-Tooth disease |
| RS34227834 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS34231402 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS34236392 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Rothmund-Thomson syndrome |
| RS34237929 |
LRBA
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to LRBA deficiency, Combined immunodeficiency due to LRBA deficiency |
| RS34238319 |
PGM3
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 23, Immunodeficiency 23 |
| RS34238807 |
CLN8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 8, Neuronal ceroid lipofuscinosis 8 |
| RS34238989 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS34239530 |
FGL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS34239729 |
GSS
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutathione synthetase deficiency with 5-oxoprolinuria, Glutathione synthetase deficiency with 5-oxoprolinuria |
| RS34245038 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis syndrome, Tuberous sclerosis 2 |
| RS34245321 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS34246477 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema |
| RS34248551 |
ZFPM2
|
Health Risk |
Conflicting classifications of pathogenicity |
46, XY sex reversal 9 |
| RS34248917 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Senior-Loken syndrome 4 |
| RS34254740 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS34256013 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Upshaw-Schulman syndrome, ADAMTS13-related disorder |
| RS34256381 |
GNPTAB
|
Health Risk |
Pathogenic |
Mucolipidosis type II, Mucolipidosis type II |
| RS34258482 |
MMACHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Disorders of Intracellular Cobalamin Metabolism, Cobalamin C disease |
| RS34261028 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS34263845 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS34271731 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS34275677 |
MBD4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS34279942 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Inborn genetic diseases |
| RS34282684 |
HBB
|
Health Risk |
Pathogenic |
beta Thalassemia, 9 conditions |
| RS34282765 |
STX11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 4, Familial hemophagocytic lymphohistiocytosis 4 |
| RS34283928 |
TUFM
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 4, Inborn genetic diseases |
| RS34291397 |
ERCC5
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group G |
| RS34292387 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS34295337 |
ERCC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Xeroderma pigmentosum group B, Xeroderma pigmentosum |
| RS34295987 |
LMF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lipase deficiency, combined |
| RS34301677 |
TMPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 2, Loeys-Dietz syndrome 2 |
| RS34305195 |
HBB
|
Health Risk |
Pathogenic/Likely pathogenic |
beta Thalassemia, BETA-PLUS-THALASSEMIA |
| RS34306618 |
GPI
|
Health Risk |
Likely pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS34309090 |
SDHB
|
Health Risk |
Pathogenic |
Hereditary pheochromocytoma and paraganglioma, Hereditary pheochromocytoma and paraganglioma |
| RS34309943 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS34312619 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS34313388 |
TNNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS34313885 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS34314610 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS34314728 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS34315917 |
ATP8B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 1, Progressive familial intrahepatic cholestasis type 1 |
| RS34316445 |
FBXO7
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinsonian-pyramidal syndrome, FBXO7-related disorder |
| RS34319539 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS34322868 |
CCN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |